Inactive Instrument

Amylin Pharmaceuticals LLC Stock

Stocks

End-of-day quote Nasdaq
- ^USD	-

12-08-02	Bristol Myers Squibb Co. : Bristol-Myers executive charged with insider trading	RE
12-07-16	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	RE

12-08-02	Bristol Myers Squibb Co. : Bristol-Myers executive charged with insider trading	RE
12-07-16	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	RE
12-07-16	GlaxoSmithKline plc : Exclusive: GSK set for Human Genome takeover - sources	RE
12-07-15	GlaxoSmithKline plc : GSK in weekend talks to buy Human Genome: sources	RE
12-07-10	Forest Laboratories, Inc. : Exclusive: Icahn offered to settle with Forest before battle	RE
12-07-10	Exclusive: Icahn offered to settle with Forest before battle	RE
12-07-02	SANOFI : Icahn return on Amylin tops 35 percent	RE
12-07-02	Bristol Myers Squibb Co. : Bristol's patent woes persist despite Amylin buy	RE
12-06-30	SANOFI : AstraZeneca hungry to refill medicine cabinet	RE
12-06-29	SANOFI : Bristol-Myers to buy Amylin for about $5.3 billion	RE
12-05-02	Ardea Biosciences, Inc. : Biotech targets fight back as Big Pharma circles	RE
12-04-30	Ardea Biosciences, Inc. : Warner Chilcott to explore sale of company	RE
12-04-25	Ardea Biosciences, Inc. : Watson to buy Actavis for at least $5.6 billion	RE

12-08-09	Amylin Pharmaceuticals, Inc. : Bristol-Myers Squibb and AstraZeneca Complete Expansion of Diabetes Alliance Through Bristol-Myers Squibb's Acquisition of Amylin	PU
12-07-11	Amylin Pharmaceuticals, Inc. : The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin Pharmaceuticals, Inc. in Connection with the Sale of the Company to Bristol-Myers Squibb Corporation	BU
12-07-09	Amylin Pharmaceuticals, Inc. : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc.	PR
12-07-07	Amylin Pharmaceuticals, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.	BU
12-07-03	Amylin Pharmaceuticals, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.	PR

12-07-16	GSK annonce le rachat de Human Genome pour $3,0 milliards
12-07-02	Wall Street termine sans grande tendance après les PMI
12-07-02	USA-Les valeurs à suivre à Wall Street
12-06-30	Le laboratoire Bristol-Myers lance une OPA amicale sur Amylin
12-05-31	Sanofi veut élargir son offre sur le marché du diabète

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REGENERON PHARMACEUTICALS, INC.	+0.68%	+2.83%	+45.56%	+0.34%	82.73B
CSL LIMITED	+2.68%	+29.00%	-19.83%	-34.19%	57.94B
MODERNA, INC.	+14.63%	+149.65%	+520.04%	+40.43%	55.45B
SAMSUNG BIOLOGICS CO.,LTD.	+0.76%	+2.39%	+0.08%	+35.11%	52.57B
UCB	+1.86%	+3.13%	+11.49%	+174.36%	48.94B
BIOGEN INC.	+1.47%	+4.03%	+62.15%	-16.38%	32.23B
INCYTE CORPORATION	+1.66%	+5.26%	+53.34%	+103.52%	25.94B
INNOVENT BIOLOGICS, INC.	+0.60%	+4.98%	+0.65%	+188.89%	22.1B
SWEDISH ORPHAN BIOVITRUM AB	+3.89%	+1.08%	+61.82%	+112.10%	16.55B
Average	+3.14%	+17.75%	+81.70%	+67.13%	43.83B
Weighted average by Cap.	+3.36%	+21.99%	+92.40%	+47.80%